Format

Send to

Choose Destination
Future Oncol. 2017 May;13(12):1105-1114. doi: 10.2217/fon-2016-0481. Epub 2017 Feb 2.

Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.

Author information

1
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
2
Department of Specialist Clinical & Odontostomatological Sciences, Università Politecnica delle Marche, Ancona, Italy.
3
Division of Oncology, S Orsola-Malpighi Hospital, Bologna, Italy.
4
Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
5
Department of Surgery & Pathology, Faculty of Medicine, Cordoba University Medical School, Cordoba, Spain.
6
Champalimaud Clinical Center, Lisbon, Portugal.

Abstract

Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.

KEYWORDS:

angiogenesis; chemokines; prostate cancer; renal cancer

PMID:
28147707
DOI:
10.2217/fon-2016-0481
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center